Sandra BERNDT

Person

Hohen Neuendorf, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates with enzymatically cleavable groups
- Patent number 12,144,865
- Issue date Nov 19, 2024
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using CCR8 antibodies
- Patent number 12,065,497
- Issue date Aug 20, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Grant
Prodrugs of cytotoxic active agents having enzymatically cleavable...
- Patent number 11,685,714
- Issue date Jun 27, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
- Patent number 11,660,351
- Issue date May 30, 2023
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
- Patent number 11,478,554
- Issue date Oct 25, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody drug conjugates (ADCs) having KSP inhibitors
- Patent number 11,433,140
- Issue date Sep 6, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CCR8 antibodies for therapeutic applications
- Patent number 11,427,640
- Issue date Aug 30, 2022
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Grant
Substituted pyrrolopyridine-derivatives
- Patent number 11,427,578
- Issue date Aug 30, 2022
- Bayer Pharma Aktiengesellschaft
- Jeffrey Stuart Mowat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) and antibody prodrug conjugates (AP...
- Patent number 11,123,439
- Issue date Sep 21, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 11,071,788
- Issue date Jul 27, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylate...
- Patent number 10,485,880
- Issue date Nov 26, 2019
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
- Patent number 10,022,453
- Issue date Jul 17, 2018
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240400700
- Publication date Dec 5, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240376218
- Publication date Nov 14, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240174683
- Publication date May 30, 2024
- Bayer Aktiengesellschaft
- Ulrich LÜCKING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20240043379
- Publication date Feb 8, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20230338559
- Publication date Oct 26, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION
- Publication number 20230250178
- Publication date Aug 10, 2023
- Bayer Aktiengesellschaft
- Sandra BERNDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...
- Publication number 20230039341
- Publication date Feb 9, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20220362392
- Publication date Nov 17, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20220363768
- Publication date Nov 17, 2022
- Bayer Aktiengesellschaft
- Sandra Berndt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES
- Publication number 20220047603
- Publication date Feb 17, 2022
- Bayer Aktiengesellschaft
- Jeffrey Stuart MOWAT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20220016258
- Publication date Jan 20, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20200138970
- Publication date May 7, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20190365916
- Publication date Dec 5, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20190328897
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20190077752
- Publication date Mar 14, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318438
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180185510
- Publication date Jul 5, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...
- Publication number 20180169256
- Publication date Jun 21, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES (ADCS) OF KSP INHIBITORS WITH AGLYCOSYLATE...
- Publication number 20180015176
- Publication date Jan 18, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) WITH KINESIN SPINDEL PROTEIN (KSP)
- Publication number 20160346402
- Publication date Dec 1, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TWEAKR ANTIBODIES AND USES THEREOF
- Publication number 20160237160
- Publication date Aug 18, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Christian VOTSMEIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Sandra BERNDT

Person

Patents Grantslast 30 patents

Antibody drug conjugates with enzymatically cleavable groups

Methods of treatment using CCR8 antibodies

Prodrugs of cytotoxic active agents having enzymatically cleavable...

Antibody drug conjugates (ADCs) having enzymatically cleavable groups

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

Specific antibody drug conjugates (ADCs) having KSP inhibitors

CCR8 antibodies for therapeutic applications

Substituted pyrrolopyridine-derivatives

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (AP...

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylate...

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

Patents Applicationslast 30 patents

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

MAP4K1 INHIBITORS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION

ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...

ANTIBODY-DRUG CONJUGATES (ADCS) OF KSP INHIBITORS WITH AGLYCOSYLATE...

ANTIBODY DRUG CONJUGATES (ADCS) WITH KINESIN SPINDEL PROTEIN (KSP)

ANTI-TWEAKR ANTIBODIES AND USES THEREOF